# Effect of Acetazolamide on Cognition in Patients With Respiratory Disease at Altitude

> **NCT03165890** · PHASE4 · COMPLETED · sponsor: **University of Zurich** · enrollment: 78 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** ACETAZOLAMIDE oral capsule
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03165890
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-24
- **Primary completion:** 2017-07-24
- **Final completion:** 2017-07-24
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2019-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03165890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03165890, "Effect of Acetazolamide on Cognition in Patients With Respiratory Disease at Altitude". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03165890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*